Qube Research & Technologies (QRT)
OCDX

Qube Research & Technologies (QRT)’s Ortho Clinical Diagnostics Holdings plc Ordinary Shares OCDX Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio OCDX Stock Details OCDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-192,462
Closed -$3.59M – 3344
2022
Q1 		$3.59M Buy
192,462
+83,871
+77% +$1.51M 0.03% 604
2021
Q4 		$2.32M Buy
108,591
+87,125
+406% +$1.72M 0.02% 791
2021
Q3 		$397K Buy
+21,466
New +$432K 0.01% 1344

Other funds holding OCDX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Qube Research & Technologies (QRT)'s OCDX Position: Q2 2022 in Review

Qube Research & Technologies (QRT) sold out of Ortho Clinical Diagnostics Holdings plc Ordinary Shares (OCDX) in Q2 2022, closing a stake of 192,462 shares — an estimated $3.59M sold.

Qube Research & Technologies (QRT) first reported a position in OCDX in Q3 2021 and held it in 3 quarters. The position peaked at $3.59M in Q1 2022. 1 fund tracked by Wall St. Rank holds OCDX as of Q2 2022.

  • Qube Research & Technologies (QRT) reported no remaining Ortho Clinical Diagnostics Holdings plc Ordinary Shares position as of Q2 2022 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 192,462 Ortho Clinical Diagnostics Holdings plc Ordinary Shares shares in Q2 2022, an estimated $3.59M.
  • Qube Research & Technologies (QRT) first reported a position in Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q3 2021 and held it in 3 quarters.
  • Qube Research & Technologies (QRT)'s Ortho Clinical Diagnostics Holdings plc Ordinary Shares position peaked at $3.59M in Q1 2022.
  • 1 fund tracked by Wall St. Rank held Ortho Clinical Diagnostics Holdings plc Ordinary Shares as of Q2 2022.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2022, filed 15 Aug 2022.